Brief: Biotec Pharmacon EBITDA loss widens to NOK 5.9 million
26/10/2016 06:00
Oct 26 (Reuters) - Biotec Pharmacon ASA BIOTEC.OL :
* Q3 revenue 21.1 million Norwegian crowns ($2.5 million)
versus 16.4 million crowns year ago
* Q3 EBITDA loss 5.9 million crowns versus loss 3.5 million
crowns year ago
* Reiterates its 2016 operational targets for Woulgan,
presented at company's capital markets day on Feb. 11 2016
Source text for Eikon: ID:nObiVvSKYa
Further company coverage: BIOTEC.OL
($1 = 8.2709 Norwegian crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))